Verrica Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
15.12.23
/
50%
€5.10
Target price
15.12.24
€9.18
Performance (%)
-86.93%
End price
16.12.24
€0.67
Summary
This prediction ended on 16.12.24 with a price of €0.67. Massive losses of -86.93% were the result for the BUY prediction by Jefferies_Financial_. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten